A New Dawn: First CAR T Cell Recommended for FDA Approval – Medscape
Medscape |
A New Dawn: First CAR T Cell Recommended for FDA Approval
Medscape A new dawn is breaking in the field of hematologic malignancies, as the first product based on chimeric antigen receptor (CAR) T cells was scrutinized today by a panel of experts and unanimously recommended for approval. All 10 panel members at today’s … Novel cancer treatment wins endorsement of FDA advisersWashington Post CAR–T gene therapy for leukemia clears FDA hurdleCBS News FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer KillersFortune Markets Insider –STAT –NBCNews.com all 84 news articles » |
CNBC |
Pioneering cancer gene therapy by Novartis backed by US panel
CNBC Novartis AG’s pioneering cancer drug won the backing of a federal advisory panel on Wednesday, paving the way for the first gene therapy to be approved in the United States. An advisory panel to the Food and Drug Administration voted 10-0 that the drug … FDA panel backs Novartis’ pioneering new cancer gene therapyReuters Novel Leukemia Treatment Could Be 1st US Gene TherapyU.S. News & World Report CAR-T gene therapy for leukemia clears FDA hurdleCBS News Fox News –TIME –Sun Sentinel all 74 news articles » |
Washington Post |
Novel cancer treatment wins endorsement of FDA advisers
Washington Post Novartis, the drugmaker behind the CAR T-cell therapy, is seeking approval to use it for children and young adults whose leukemia doesn’t respond to traditional treatments — a group that numbers 600 or so patients a year in this country. But the … A New Dawn: First CAR T Cell Recommended for FDA ApprovalMedscape FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer KillersFortune Novartis’ stellar CAR–T efficacy data steamrolls safety doubts to power landmark cancer therapy toward approvalFierceBiotech ABC News –CBS News –FDA –New York Times all 245 news articles » |
Retraction Watch (blog) |
Nature retracts paper by stem cell scientist appealing her dismissal
Retraction Watch (blog) A once-rising star in stem cell biology — who recently lost both her job and a sizable grant — has had a fourth paper retracted. The notice — issued by Nature for a 2006 letter — cites duplicated images, and a lack of raw data to verify the … |
Motherboard |
Neill Blomkamp’s Latest Short Film ‘Zygote’ Is Pure Biological Horror
Motherboard It tackles ideas including the creation of artificial humans, labor, synthetic biology, and more, through the lens of a creepy survival thriller. Blomkamp (director of District 9, Chappie, and Elysium) launched Oats Studios earlier this year as a new … |
WRAL Tech Wire |
Tech wrap: FDA gene therapy review; face scan wories; Google tax victory; $1B electric car plant KO’d
WRAL Tech Wire The Food and Drug Administration panel is holding a hearing Wednesday to discuss the treatment developed by the University of Pennsylvania and Novartis Corp. The drugmaker is seeking approval to use the one-time treatment for children and young … |